Bilal Omer MD

Pediatric Hematology & Oncology•Houston, TX

Clinical Postdoc Fellow, Pediatric Hematology & Oncology, Baylor College of Medicine

Join to View Full Profile

6701 Fannin StTch Children's Cancer Center Cc 1510.00Houston, TX 77030
Phone+1 832-822-4242
Fax+1 832-825-1453

Education & Training

Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2010 - 2013
Yale-New Haven Medical CenterResidency, Internal Medicine/Pediatrics, 2005 - 2009
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2005

Certifications & Licensure

TX State Medical License 2013 - 2025
CT State Medical License 2008 - 2010
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant Start of enrollment: 2014 Jun 01
Completed
Not Applicable
Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C) Start of enrollment: 2015 Sep 01
Completed
Phase 1
Administration of Donor MultiTAA-Specific T Cells for ALL
COMPLETED
PHASE1
C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) Start of enrollment: 2019 Apr 23
ACTIVE_NOT_RECRUITING
PHASE1
C7R-GD2.CAR T Cells for Patients with GD2-expressing Brain Tumors (GAIL-B) Start of enrollment: 2020 Feb 03
RECRUITING
PHASE1
EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma Start of enrollment: 2022 Oct 31
RECRUITING
PHASE1
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors.
Aaron B Ross, Kriti Puri, Thomas L Johnson, Lilliam D Correa, Tami D John
Pediatric Blood & Cancer. 2025-04-01
1 citations
Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors.
Anne Miller, Rachel Daum, Tao Wang, Mengfen Wu, Candise Tat
Cytotherapy. 2024-09-01
11 citations
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.
Frank Y Lin, Austin Stuckert, Candise Tat, Mark White, Lucia Ruggieri
Journal of Clinical Oncology. 2024-08-10

Abstracts/Posters

CD70-Specific CAR T Cells Have Potent Activity Against Acute Myeloid Leukemia (AML) without HSC Toxicity
Bilal Omer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Myeloablative Conditioning with Alemtuzumab in Matched Related Donor Hematopoietic Cell Transplant for Sickle Cell Disease Prevents Graft-Versus-Host Disease without C...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Baylor College of Medicine Receives More Than $17 Million from CPRITAugust 21st, 2024
Off-the-Shelf T-cell Therapy Effective Against Viral Infections After Allo-HCTJanuary 13th, 2023
T-cell Therapy Fights Viral Infections Following Stem Cell TransplantsJanuary 13th, 2023
Join now to see all

Other Languages

German